actors to be
used to stratify
analysis)

None or Leg edema reduction
heparan
assessed by volumetry, and
sulphate
venous symptoms
(heaviness, tingling and
pain).
Decrease of pain, cramps,
heaviness, edema and total
symptoms score. Reduced
inï¬‚ammatory mediators.
Low risk of adverse events
(3%)

Systematic review
and meta-analysis
of 1